| NCT Number | NCT07436312 |
| Lead Sponsor | Gustave Roussy, Cancer Campus, Grand Paris |
| Conditions | Breast Cancer, Pancreas Cancer, Colon Cancer, Lynch Syndrome, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation |
| Enrollment | 170 participants |
| Start Date | 2026-05-04 |
| Primary Completion | 2027-09 (estimated) |
| Study Completion | 2028-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-08 |